Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABAX --- lots of upside -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (417)	4/6/1998 6:29:00 PM
From: burner	Read Replies (1) \| Respond to of 492

David et al: Monday April 6, 3:32 pm Eastern Time Company Press Release SOURCE: Abaxis, Inc. Abaxis Announces New Investor Relations Management Firm SUNNYVALE, Calif., April 6 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX - news) has retained the services of Jackson Hole Advisors to assist the company in managing investor relations, especially in expanding support for Abaxis in the brokerage community and the domestic equity markets generally. Jackson Hole Advisors is a private consulting firm whose principals have been active in the brokerage and investment banking community since 1969 and have been providing private client consulting services since 1989. The objective of management in retaining Jackson Hole Advisors is to build market support by communicating to the brokerage community and the markets as a whole, the growth with discipline strategy at Abaxis that has, for the nine months ended December 31, 1997, expanded sales revenue 99.15%, increased gross margin on sales 154.93%, and reduced net cash used in operations by 81.65%. Management believes that in order to strengthen the connection between Abaxis' share value and operational performance and to position itself to access the public markets, it must expand its strategic relationships with the brokerage and domestic investment banking community. Abaxis develops, manufactures and markets portable blood analysis systems for use in any patient care setting to provide clinicians with rapid blood constituent measurements. The company's products consist of a compact 15.25 lb. (6.9 kilogram) analyzer and a series of single-use plastic disks called reagent disks that contain all the chemicals required to perform a panel of up to 12 tests. The system can be operated with minimal training and performs multiple routine tests on whole blood using either venous or fingerstick samples. The system provides test results in less than 15 minutes with the precision and accuracy equivalent to tests performed by a clinical laboratory. The company currently markets this system for human use under the name Piccolo and for veterinary use under the name VetScan.